220 related articles for article (PubMed ID: 7363708)
21. Controlled trial of aztreonam vs. tobramycin and azlocillin for acute pulmonary exacerbations of cystic fibrosis.
Bosso JA; Black PG
Pediatr Infect Dis J; 1988 Mar; 7(3):171-6. PubMed ID: 3128767
[TBL] [Abstract][Full Text] [Related]
22. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic.
Daikos GK; Giamarellou H; Hadjipolydorou K; Kanellakopoulou K
Arzneimittelforschung; 1979; 29(12a):1976-8. PubMed ID: 120747
[TBL] [Abstract][Full Text] [Related]
23. [Role of azlocillin in the treatment of Pseudomonas urinary infections].
Canton P
Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606
[TBL] [Abstract][Full Text] [Related]
24. [Azlocillin in the treatment of pulmonary infections in patients with cystic fibrosis: plasma concentrations and therapeutic indications].
Rosselli P; Marianelli L; Valenza T; Bartolozzi G
Pediatr Med Chir; 1989; 11(4):389-91. PubMed ID: 2694104
[TBL] [Abstract][Full Text] [Related]
25. High dosage tobramycin treatment of children with cystic fibrosis. Bacteriological effect and clinical ototoxicity.
Thomsen J; Friis B
Int J Pediatr Otorhinolaryngol; 1979 Jul; 1(1):33-40. PubMed ID: 553884
[TBL] [Abstract][Full Text] [Related]
26. Anti-pseudomonas activity of azlocillin during pulmonary infection in patients with cystic fibrosis.
Levy J; Baran D; Klastersky J
J Antimicrob Chemother; 1982 Sep; 10(3):235-8. PubMed ID: 6815156
[No Abstract] [Full Text] [Related]
27. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.
Schaad UB; Desgrandchamps D; Kraemer R
Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103
[TBL] [Abstract][Full Text] [Related]
28. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
Permin H; Koch C; Høiby N; Christensen HO; Møller AF; Møller S
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():313-23. PubMed ID: 6352636
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of the efficacy and safety of azlocillin and gentamicin in the treatment of serious infections.
del Rosal PL
J Antimicrob Chemother; 1983 May; 11 Suppl B():159-67. PubMed ID: 6352599
[TBL] [Abstract][Full Text] [Related]
30. [Pharmakokinetic and clinical studies with azlocillin in paediatrics (author's transl)].
Weingärtner L; Sitka U; Patsch R; Richter I; Thiemann HH
Klin Padiatr; 1980 Sep; 192(5):419-29. PubMed ID: 7192337
[TBL] [Abstract][Full Text] [Related]
31. Ceftazidime - a significant advance in the treatment of cystic fibrosis.
David TJ; Phillips BM; Connor PJ
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():337-40. PubMed ID: 6352639
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial chemotherapy in patients with cystic fibrosis.
Guggenbichler JP; Schneeberger J
Infection; 1987; 15(5):397-402. PubMed ID: 3692614
[TBL] [Abstract][Full Text] [Related]
33. [Monotherapy of Pseudomonas aeruginosa septicemia with azlocillin].
Godard J; Aubertin J; Borderon JC; Dureux JB; Motin J
Presse Med; 1984 Mar; 13(13):819-21. PubMed ID: 6231603
[TBL] [Abstract][Full Text] [Related]
34. Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients.
Bingen E; Denamur E; Picard B; Goullet P; Lambert-Zechovsky N; Foucaud P; Navarro J; Elion J
Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):432-7. PubMed ID: 1358612
[TBL] [Abstract][Full Text] [Related]
35. Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Lau WK; Young LS; Osher AB; Dooley RR
Pediatrics; 1977 Sep; 60(3):372-7. PubMed ID: 408787
[TBL] [Abstract][Full Text] [Related]
36. Carbenicillin treatment of Pseudomonas pulmonary infection. Use in children with cystic fibrosis.
Phair JP; Tan JS; Watanakunakorn C; Schwab L; Sanders LW
Am J Dis Child; 1970 Jul; 120(1):22-5. PubMed ID: 4316325
[No Abstract] [Full Text] [Related]
37. Experience with ceftazidime in cystic fibrosis.
Dodge J; Zamiri I; Goodchild M; Ingram P
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():325-9. PubMed ID: 6352637
[TBL] [Abstract][Full Text] [Related]
38. Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.
Høiby N; Koch C
Thorax; 1990 Nov; 45(11):881-4. PubMed ID: 2256020
[No Abstract] [Full Text] [Related]
39. [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].
Bauernfeind A; Petermüller C; Dietzel M
Infection; 1979; 7(1):21-6. PubMed ID: 422252
[TBL] [Abstract][Full Text] [Related]
40. A comparison of azlocillin and gentamicin in the treatment of serious infections caused by Pseudomonas aeruginosa.
Gonzalez MA
J Antimicrob Chemother; 1983 May; 11 Suppl B():169-74. PubMed ID: 6352600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
